Sotera Health (NASDAQ:SHC) Short Interest Down 18.7% in December

Sotera Health (NASDAQ:SHC - Get Free Report) was the recipient of a significant decrease in short interest in December. As of December 15th, there was short interest totalling 6,610,000 shares, a decrease of 18.7% from the November 30th total of 8,130,000 shares. Based on an average daily trading volume, of 1,260,000 shares, the days-to-cover ratio is presently 5.2 days. Currently, 4.3% of the company's stock are sold short.

Hedge Funds Weigh In On Sotera Health

A number of hedge funds have recently modified their holdings of SHC. True Wealth Design LLC acquired a new position in Sotera Health in the third quarter worth approximately $32,000. GAMMA Investing LLC increased its stake in shares of Sotera Health by 125.0% during the 3rd quarter. GAMMA Investing LLC now owns 2,988 shares of the company's stock worth $50,000 after purchasing an additional 1,660 shares during the last quarter. Point72 DIFC Ltd raised its holdings in shares of Sotera Health by 556.6% during the 2nd quarter. Point72 DIFC Ltd now owns 6,540 shares of the company's stock valued at $78,000 after purchasing an additional 5,544 shares in the last quarter. Capital Performance Advisors LLP acquired a new stake in shares of Sotera Health in the 3rd quarter valued at $91,000. Finally, Acadian Asset Management LLC boosted its holdings in Sotera Health by 728.0% in the second quarter. Acadian Asset Management LLC now owns 9,381 shares of the company's stock worth $111,000 after purchasing an additional 8,248 shares in the last quarter. 91.03% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

SHC has been the subject of a number of recent research reports. Citigroup boosted their price objective on shares of Sotera Health from $18.00 to $20.00 and gave the company a "buy" rating in a research report on Wednesday, November 6th. The Goldman Sachs Group assumed coverage on Sotera Health in a report on Friday, December 6th. They set a "neutral" rating and a $14.00 target price for the company. Finally, Royal Bank of Canada reiterated an "outperform" rating and set a $17.00 price target on shares of Sotera Health in a research report on Thursday, November 21st. Three research analysts have rated the stock with a hold rating and four have issued a buy rating to the company. Based on data from MarketBeat, the company presently has an average rating of "Moderate Buy" and a consensus price target of $16.08.

Sotera Health Trading Down 0.2 %

Shares of NASDAQ SHC traded down $0.03 during mid-day trading on Friday, hitting $13.48. 694,536 shares of the company traded hands, compared to its average volume of 1,332,887. The company has a quick ratio of 2.61, a current ratio of 2.88 and a debt-to-equity ratio of 4.91. Sotera Health has a 1 year low of $10.71 and a 1 year high of $17.44. The stock has a market capitalization of $3.82 billion, a price-to-earnings ratio of 53.92 and a beta of 1.96. The business has a 50 day moving average of $14.17 and a two-hundred day moving average of $14.29.

Sotera Health (NASDAQ:SHC - Get Free Report) last released its earnings results on Tuesday, November 5th. The company reported $0.17 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.18 by ($0.01). The business had revenue of $285.47 million during the quarter, compared to analysts' expectations of $278.64 million. Sotera Health had a net margin of 6.31% and a return on equity of 42.27%. Sotera Health's revenue for the quarter was up 8.5% on a year-over-year basis. During the same quarter in the previous year, the company earned $0.18 EPS. On average, sell-side analysts anticipate that Sotera Health will post 0.61 earnings per share for the current fiscal year.

About Sotera Health

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.